annual net income:
-$321.55M-$210.15M(-188.64%)Summary
- As of today (June 18, 2025), TVTX annual net profit is -$321.55 million, with the most recent change of -$210.15 million (-188.64%) on December 31, 2024.
- During the last 3 years, TVTX annual net income has fallen by -$141.45 million (-78.55%).
- TVTX annual net income is now -374.27% below its all-time high of $117.24 million, reached on December 31, 2015.
Performance
TVTX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$41.23M+$19.04M(+31.59%)Summary
- As of today (June 18, 2025), TVTX quarterly net profit is -$41.23 million, with the most recent change of +$19.04 million (+31.59%) on March 31, 2025.
- Over the past year, TVTX quarterly net income has increased by +$94.83 million (+69.70%).
- TVTX quarterly net income is now -127.35% below its all-time high of $150.74 million, reached on September 30, 2023.
Performance
TVTX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$226.71M+$94.83M(+29.49%)Summary
- As of today (June 18, 2025), TVTX TTM net profit is -$226.71 million, with the most recent change of +$94.83 million (+29.49%) on March 31, 2025.
- Over the past year, TVTX TTM net income has dropped by -$65.58 million (-40.70%).
- TVTX TTM net income is now -293.38% below its all-time high of $117.24 million, reached on December 31, 2015.
Performance
TVTX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TVTX Net income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -188.6% | +69.7% | -40.7% |
3 y3 years | -78.5% | +45.7% | -12.1% |
5 y5 years | -119.6% | -5202.2% | -116.7% |
TVTX Net income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -188.6% | at low | -127.3% | +69.7% | -160.4% | +35.5% |
5 y | 5-year | -188.6% | at low | -127.3% | +69.7% | -190.4% | +35.5% |
alltime | all time | -374.3% | at low | -127.3% | +69.7% | -293.4% | +35.5% |
TVTX Net income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$41.23M(-31.6%) | -$226.71M(-29.5%) |
Dec 2024 | -$321.55M(+188.6%) | -$60.26M(+9.9%) | -$321.55M(-8.5%) |
Sep 2024 | - | -$54.81M(-22.2%) | -$351.45M(+140.9%) |
Jun 2024 | - | -$70.41M(-48.3%) | -$145.91M(-9.4%) |
Mar 2024 | - | -$136.06M(+50.9%) | -$161.13M(+44.6%) |
Dec 2023 | -$111.40M(-60.0%) | -$90.17M(-159.8%) | -$111.40M(+28.0%) |
Sep 2023 | - | $150.74M(-276.0%) | -$87.05M(-71.7%) |
Jun 2023 | - | -$85.63M(-0.8%) | -$307.44M(+6.4%) |
Mar 2023 | - | -$86.33M(+31.2%) | -$288.84M(+3.7%) |
Dec 2022 | -$278.48M(+54.6%) | -$65.82M(-5.5%) | -$278.48M(+5.4%) |
Sep 2022 | - | -$69.66M(+3.9%) | -$264.23M(+14.8%) |
Jun 2022 | - | -$67.03M(-11.8%) | -$230.22M(+13.9%) |
Mar 2022 | - | -$75.97M(+47.3%) | -$202.19M(+12.3%) |
Dec 2021 | -$180.09M(+6.3%) | -$51.57M(+44.7%) | -$180.09M(-28.0%) |
Sep 2021 | - | -$35.64M(-8.6%) | -$250.14M(+5.5%) |
Jun 2021 | - | -$39.01M(-27.6%) | -$237.05M(+5.8%) |
Mar 2021 | - | -$53.87M(-55.7%) | -$224.11M(+32.3%) |
Dec 2020 | -$169.43M(+15.7%) | -$121.62M(+439.4%) | -$169.43M(+117.0%) |
Sep 2020 | - | -$22.55M(-13.5%) | -$78.07M(-15.2%) |
Jun 2020 | - | -$26.07M(-3326.2%) | -$92.01M(-12.1%) |
Mar 2020 | - | $808.00K(-102.7%) | -$104.64M(-28.5%) |
Dec 2019 | -$146.43M(+42.6%) | -$30.26M(-17.1%) | -$146.43M(+18.4%) |
Sep 2019 | - | -$36.49M(-5.7%) | -$123.62M(-12.7%) |
Jun 2019 | - | -$38.70M(-5.6%) | -$141.65M(+13.1%) |
Mar 2019 | - | -$40.98M(+449.7%) | -$125.28M(+22.0%) |
Dec 2018 | -$102.68M(+71.9%) | -$7.46M(-86.3%) | -$102.68M(-9.0%) |
Sep 2018 | - | -$54.52M(+144.1%) | -$112.84M(+48.2%) |
Jun 2018 | - | -$22.33M(+21.5%) | -$76.12M(+13.6%) |
Mar 2018 | - | -$18.38M(+4.3%) | -$67.02M(+12.2%) |
Dec 2017 | -$59.73M | -$17.62M(-1.0%) | -$59.73M(+17.8%) |
Sep 2017 | - | -$17.79M(+34.5%) | -$50.72M(-27.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2017 | - | -$13.23M(+19.3%) | -$70.03M(-0.2%) |
Mar 2017 | - | -$11.09M(+28.9%) | -$70.21M(+46.6%) |
Dec 2016 | -$47.90M(-140.9%) | -$8.60M(-76.8%) | -$47.90M(+14.7%) |
Sep 2016 | - | -$37.11M(+176.9%) | -$41.77M(-141.4%) |
Jun 2016 | - | -$13.40M(-219.5%) | $100.92M(+13.7%) |
Mar 2016 | - | $11.22M(-554.3%) | $88.80M(-24.3%) |
Dec 2015 | $117.24M(-205.7%) | -$2.47M(-102.3%) | $117.24M(+29.3%) |
Sep 2015 | - | $105.58M(-513.6%) | $90.68M(-375.8%) |
Jun 2015 | - | -$25.53M(-164.4%) | -$32.88M(-838.4%) |
Mar 2015 | - | $39.66M(-236.6%) | $4.45M(-104.0%) |
Dec 2014 | -$110.94M(+220.4%) | -$29.03M(+61.4%) | -$110.94M(+15.7%) |
Sep 2014 | - | -$17.98M(-252.3%) | -$95.85M(+8.0%) |
Jun 2014 | - | $11.80M(-115.6%) | -$88.76M(-16.0%) |
Mar 2014 | - | -$75.74M(+443.5%) | -$105.62M(+203.9%) |
Dec 2013 | -$34.63M(+14.1%) | -$13.94M(+27.9%) | -$34.75M(+66.9%) |
Sep 2013 | - | -$10.90M(+115.9%) | -$20.82M(+109.8%) |
Jun 2013 | - | -$5.05M(+3.7%) | -$9.92M(+103.4%) |
Mar 2013 | - | -$4.87M(>+9900.0%) | -$4.88M(>+9900.0%) |
Dec 2012 | -$30.34M(>+9900.0%) | - | - |
Nov 2012 | - | -$3700.00(+5.7%) | -$15.00K(+1.4%) |
Aug 2012 | - | -$3500.00(0.0%) | -$14.80K(0.0%) |
May 2012 | - | -$3500.00(-18.6%) | -$14.80K(0.0%) |
Feb 2012 | - | -$4300.00(+22.9%) | -$14.80K(+1.4%) |
Feb 2012 | -$14.80K(-35.7%) | - | - |
Nov 2011 | - | -$3500.00(0.0%) | -$14.60K(-13.1%) |
Aug 2011 | - | -$3500.00(0.0%) | -$16.80K(-15.6%) |
May 2011 | - | -$3500.00(-14.6%) | -$19.90K(-13.5%) |
Feb 2011 | -$23.00K | -$4100.00(-28.1%) | -$23.00K(+21.7%) |
Nov 2010 | - | -$5700.00(-13.6%) | -$18.90K(+43.2%) |
Aug 2010 | - | -$6600.00(0.0%) | -$13.20K(+100.0%) |
May 2010 | - | -$6600.00 | -$6600.00 |
FAQ
- What is Travere Therapeutics annual net profit?
- What is the all time high annual net income for Travere Therapeutics?
- What is Travere Therapeutics annual net income year-on-year change?
- What is Travere Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Travere Therapeutics?
- What is Travere Therapeutics quarterly net income year-on-year change?
- What is Travere Therapeutics TTM net profit?
- What is the all time high TTM net income for Travere Therapeutics?
- What is Travere Therapeutics TTM net income year-on-year change?
What is Travere Therapeutics annual net profit?
The current annual net income of TVTX is -$321.55M
What is the all time high annual net income for Travere Therapeutics?
Travere Therapeutics all-time high annual net profit is $117.24M
What is Travere Therapeutics annual net income year-on-year change?
Over the past year, TVTX annual net profit has changed by -$210.15M (-188.64%)
What is Travere Therapeutics quarterly net profit?
The current quarterly net income of TVTX is -$41.23M
What is the all time high quarterly net income for Travere Therapeutics?
Travere Therapeutics all-time high quarterly net profit is $150.74M
What is Travere Therapeutics quarterly net income year-on-year change?
Over the past year, TVTX quarterly net profit has changed by +$94.83M (+69.70%)
What is Travere Therapeutics TTM net profit?
The current TTM net income of TVTX is -$226.71M
What is the all time high TTM net income for Travere Therapeutics?
Travere Therapeutics all-time high TTM net profit is $117.24M
What is Travere Therapeutics TTM net income year-on-year change?
Over the past year, TVTX TTM net profit has changed by -$65.58M (-40.70%)